Case Report

Published on 28 Nov 2024

Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression

in Pharmacology of Anti-Cancer Drugs

Hejing Bao
Jiani Zhang
Yuhuan Wang
Zhiting Chen
Xi Luo
Ting Li
Haoran Su
Hehong Bao
Xiaolong Cao
Liping Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448291

Original Research

Published on 28 Nov 2024

Cepharanthine as an effective small cell lung cancer inhibitor: integrated insights from network pharmacology, RNA sequencing, and experimental validation

in Pharmacology of Anti-Cancer Drugs

Fengyun Zhao
Zhaowei Ding
Mengting Chen
Mingfang Ji
Fugui Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1517386

117 views

Correction

Accepted on 27 Nov 2024

Corrigendum: Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction

in Pharmacology of Anti-Cancer Drugs

Anita K Bakrania
Bhavesh C. Variya
Snehal S. Patel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1433625

Original Research

Accepted on 27 Nov 2024

β-caryophyllene sensitizes hepatocellular carcinoma cells to chemotherapeutics and inhibits cell malignancy through targeting MAPK signaling pathway

in Pharmacology of Anti-Cancer Drugs

Irum Basheer
Hai Wang
Guangyue Li
Shah Jehan
Ali Raza
Chentao Du
Najeeb Ullah
Dangdang Li
Guangchao Sui

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1492670

Systematic Review

Published on 27 Nov 2024

Ubiquitin-specific peptidases in lymphoma: a path to novel therapeutics

in Pharmacology of Anti-Cancer Drugs

Maryam Samareh Salavatipour
Shirin Tavakoli
Aram Halimi
Shima Tavoosi
Amir-Hossein Baghsheikhi
Abdolkarim Talebi-Taheri
Mehdi Niloufari
Zahra Salehi
Javad Verdi
Soheila Rahgozar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356634

Editorial

Published on 27 Nov 2024

Editorial: Utilizing omics strategies to discover new drug targets for cancers

in Pharmacology of Anti-Cancer Drugs

Shujun Zhang
Chen Xue
Xinyu Gu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1526976

Original Research

Published on 27 Nov 2024

Anti-tumor and anti-metastatic effects of RRx-001 on hepatocellular carcinoma: mechanisms of action and therapeutic potential

in Pharmacology of Anti-Cancer Drugs

Guohong Yan
Shuqi Zhao
Meifeng Chen
Shutian Mo
Hailian Huang
Yuan Liao
Ziyan Lu
Jiaming Liang
Shuxin Wei
Chuangye Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469825

113 views

Editorial

Published on 26 Nov 2024

Editorial: Exploring immunotherapy targets and strategies for cancer: a multi-omics perspective

in Pharmacology of Anti-Cancer Drugs

Wanchun Nie
Kailin Tang
Lu Xie
Tianyi Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1506444

Original Research

Published on 26 Nov 2024

Role of anoikis-related gene RAC3 in prognosis, immune microenvironment, and contribution to malignant behavior in vitro and in vivo of bladder urothelial carcinoma

in Pharmacology of Anti-Cancer Drugs

Yusong Zhou
Shiwei Huang
Bing Yang
Jing Tan
Zhun Zhang
Wei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503623

Case Report

Accepted on 25 Nov 2024

Therapeutic Response to Lorlatinib in Advanced Large-Cell Neuroendocrine Carcinoma of the Lung and Breast Cancer: A Heterochronous Double Malignancy Perspective

in Pharmacology of Anti-Cancer Drugs

Xiaoli Mu
Yan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413897

Original Research

Accepted on 25 Nov 2024

HDC downregulation induced by chronic stress promotes ovarian cancer progression via IL-6/STAT3/S100A9 pathway

in Pharmacology of Anti-Cancer Drugs

Zhicong Chen
Jinming Cao
Zhijun Xiao
Zhen Yang
Yuanchi Cheng
Jingjing Duan
Ting Zhou
Feng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485885

Original Research

Accepted on 25 Nov 2024

Ailanthone Blocks Mitophagy to Promote mtDNA Leakage through BAX-BAK1 Pores and Suppress Hepatocellular Carcinoma Cell Proliferation

in Pharmacology of Anti-Cancer Drugs

Yan Qin
Ying Gao
Dan Wu
Qing-qing Liu
Chang Su
Guan Liu
Le Yang
Ming-gao Zhao
Jing-yue Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1509482

Systematic Review

Accepted on 25 Nov 2024

Efficacy and safety of TACE combined with traditional Chinese medicine versus TACE alone in Hepatocellular Carcinoma: Bayesian network meta-analysis and pharmacological mechanisms study

in Pharmacology of Anti-Cancer Drugs

Li Chen
Xiu-Ling Zhu
Jie Lin
Dongliang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1495343

Original Research

Published on 25 Nov 2024

Bufonis venenum extract loaded novel cholesterol-free liposome for the treatment of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Siqi Yang
Jinshuai Lan
Zhe Li
Ming Li
Ya Wu
Liyan Sun
Tong Zhang
Yue Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486742

201 views

Mini Review

Accepted on 22 Nov 2024

Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours

in Pharmacology of Anti-Cancer Drugs

Ruiqi Chen
Chongxi Xu
Yi Tang
Xing Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485919

Original Research

Accepted on 21 Nov 2024

Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC

in Pharmacology of Anti-Cancer Drugs

Xue Li
Shimin Chen
Yuanyuan Shi
Yuanjing Wang
Qian Lin
Wenshuo Fang
Chao Wu
Leina Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464852

Navigation group

Articles

Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression

Cepharanthine as an effective small cell lung cancer inhibitor: integrated insights from network pharmacology, RNA sequencing, and experimental validation

Corrigendum: Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction

β-caryophyllene sensitizes hepatocellular carcinoma cells to chemotherapeutics and inhibits cell malignancy through targeting MAPK signaling pathway

Ubiquitin-specific peptidases in lymphoma: a path to novel therapeutics

Editorial: Utilizing omics strategies to discover new drug targets for cancers

Anti-tumor and anti-metastatic effects of RRx-001 on hepatocellular carcinoma: mechanisms of action and therapeutic potential

Editorial: Exploring immunotherapy targets and strategies for cancer: a multi-omics perspective

Role of anoikis-related gene RAC3 in prognosis, immune microenvironment, and contribution to malignant behavior in vitro and in vivo of bladder urothelial carcinoma

Therapeutic Response to Lorlatinib in Advanced Large-Cell Neuroendocrine Carcinoma of the Lung and Breast Cancer: A Heterochronous Double Malignancy Perspective

HDC downregulation induced by chronic stress promotes ovarian cancer progression via IL-6/STAT3/S100A9 pathway

Ailanthone Blocks Mitophagy to Promote mtDNA Leakage through BAX-BAK1 Pores and Suppress Hepatocellular Carcinoma Cell Proliferation

Efficacy and safety of TACE combined with traditional Chinese medicine versus TACE alone in Hepatocellular Carcinoma: Bayesian network meta-analysis and pharmacological mechanisms study

Bufonis venenum extract loaded novel cholesterol-free liposome for the treatment of hepatocellular carcinoma

Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours

Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC